Testing for Antiphospholipid antibodies with Solid Phase Assays: Guidance from the SSC of the ISTH

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 5, 2014, Pages 792-795

  Devreese, K M J ^a   Pierangeli, S S ^b   de Laat, B ^c   Tripodi, A ^d   Atsumi, T ^e   Ortel, T L ^f  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF MILAN   (Italy)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; HEMOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR; TRIACYLGLYCEROL; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; LUPUS ANTICOAGULANT;

ACCURACY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD SAMPLING; CALIBRATION; CENTRIFUGATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GOLD STANDARD; HUMAN; IMMUNOASSAY; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY CONTROL; SOLID; BLOOD; CARDIOLOGY; CHEMISTRY; CLINICAL CHEMISTRY; HEMOSTASIS; IMMUNOLOGY; INTERNATIONAL COOPERATION; MEDICAL SOCIETY; PRACTICE GUIDELINE; PROCEDURES; REPRODUCIBILITY; STANDARDS; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CALIBRATION; CARDIOLIPINS; CARDIOLOGY; CLINICAL CHEMISTRY TESTS; GUIDELINES AS TOPIC; HEMOSTASIS; HUMANS; IMMUNOASSAY; INTERNATIONAL COOPERATION; LUPUS COAGULATION INHIBITOR; REPRODUCIBILITY OF RESULTS; SOCIETIES, MEDICAL; THROMBOSIS;

EID: 84898687681     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12537     Document Type: Article

References (21)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2. Devreese KM. Standardization of antiphospholipid antibody assays. Where do we stand? Lupus 2012; 21: 718-21.
3. Devreese K, Hoylaerts MF. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome. Eur J Haematol 2009; 83: 1-16.
4. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009; 7: 1737-40.
5. Wong RC. Consensus guidelines for anticardiolipin antibody testing. Thromb Res 2004; 114: 559-71.
6. Devreese KM, van Hoecke F. Anticardiolipin and anti-beta2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays. Thromb Res 2011; 128: 598-600.
7. van Hoecke F, Persijn L, Decavele AS, Devreese K. Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Int J Lab Hematol 2012; doi: 10.1111/j.1751-553X.2012.01448.x. [Epub ahead of print].
8. De Moerloose P, Reber G, Musial J, Arnout J. Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome. J Thromb Haemost 2010; 8: 1540-6.
9. Devreese K, Hoylaerts MF. Challenges in the diagnosis of the antiphospholipid syndrome. Clin Chem 2010; 56: 930-40.
10. de Laat B, Pengo V, Pabinger I, Musial J, Voskuyl AE, Bultink IE, Ruffatti A, Rozman B, Kveder T, de Moerloose P, Boehlen F, Rand J, Ulcova-Gallova Z, Mertens K, de Groot PG. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost 2009; 7: 1767-73.
11. Devreese K, Peerlinck K, Hoylaerts MF. Diagnostic test combinations associated with thrombosis in lupus anticoagulant positive patients. Thromb Haemost 2011; 105: 736-8.
12. Pierangeli SS, Harris EN. A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc 2008; 3: 840-8.
13. Wong RC, Favaloro EJ, Adelstein S, Baumgart K, Bird R, Brighton TA, Empson M, Gillis D, Hendle MJ, Laurent R, Mallon D, Pollock W, Smith S, Steele RH, Wilson RJ. Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting. Pathology 2008; 40: 58-63.
14. Lakos G, Favaloro EJ, Harris EN, Meroni PL, Tincani A, Wong RC, Pierangeli SS. International consensus guidelines on anticardiolipin and anti-beta2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum 2012; 64: 1-10.
15. Lakos G. Interference in antiphospholipid antibody assays. Semin Thromb Hemost 2012; 38: 353-9.
16. Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004; 2: 1860-2.
17. Tincani A, Allegri F, Balestrieri G, Reber G, Sanmarco M, Meroni P, Boffa MC. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004; 114: 553-8.
18. Pierangeli SS, Favaloro EJ, Lakos G, Meroni PL, Tincani A, Wong RC, Harris EN. Standards and reference materials for the anticardiolipin and anti-beta(2)glycoprotein I assays: a report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta 2012; 413: 358-60.
19. Ruffatti A, Olivieri S, Tonello M, Bortolati M, Bison E, Salvan E, Facchinetti M, Pengo V. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification. J Thromb Haemost 2008; 6: 1693-6.
20. Clinical and Laboratory Standards Institute. Defining, Establishing and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, 3rd edn C28-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
21. Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N, Testa S, Marongiu F, Bison E, Denas G, Banzato A, Padayattil JS, Iliceto S. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 2010; 8: 237-42.